

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.24577472 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.98708922 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.98708922 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.66987116 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.47573797 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.47573797 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.47573797 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.47573797 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 5.47573797 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.47573797 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.36821919 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.25595275 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.21705980 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 5.09750824 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.96165479 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.77150192 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.65105656 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.55883334 |
| 19 | detection of other organism (GO:0098543) | 4.55688524 |
| 20 | cellular extravasation (GO:0045123) | 4.51599420 |
| 21 | response to peptidoglycan (GO:0032494) | 4.48137557 |
| 22 | detection of bacterium (GO:0016045) | 4.37470970 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 4.35300322 |
| 24 | negative regulation of interleukin-12 production (GO:0032695) | 4.25136164 |
| 25 | B cell receptor signaling pathway (GO:0050853) | 4.20266124 |
| 26 | neutrophil activation (GO:0042119) | 4.12875134 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.11859989 |
| 28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.07008254 |
| 29 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.03641552 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.97444456 |
| 31 | microglial cell activation (GO:0001774) | 3.96687173 |
| 32 | positive regulation of mast cell activation (GO:0033005) | 3.96655843 |
| 33 | respiratory burst (GO:0045730) | 3.95324935 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.94945783 |
| 35 | regulation of mast cell degranulation (GO:0043304) | 3.92073373 |
| 36 | positive regulation of B cell differentiation (GO:0045579) | 3.88860829 |
| 37 | detection of molecule of bacterial origin (GO:0032490) | 3.87620590 |
| 38 | response to host immune response (GO:0052572) | 3.84050903 |
| 39 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.84050903 |
| 40 | regulation of mast cell activation (GO:0033003) | 3.82512801 |
| 41 | myeloid cell activation involved in immune response (GO:0002275) | 3.81041099 |
| 42 | regulation of B cell differentiation (GO:0045577) | 3.80064812 |
| 43 | granulocyte activation (GO:0036230) | 3.73942699 |
| 44 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.72250882 |
| 45 | leukocyte aggregation (GO:0070486) | 3.70078422 |
| 46 | macrophage activation (GO:0042116) | 3.64491992 |
| 47 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.62753411 |
| 48 | positive thymic T cell selection (GO:0045059) | 3.60685946 |
| 49 | germinal center formation (GO:0002467) | 3.58912984 |
| 50 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.58094967 |
| 51 | positive regulation of mast cell degranulation (GO:0043306) | 3.56492321 |
| 52 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.56492321 |
| 53 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.55958994 |
| 54 | response to interleukin-15 (GO:0070672) | 3.55495864 |
| 55 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.53722743 |
| 56 | negative regulation of T cell mediated immunity (GO:0002710) | 3.52673578 |
| 57 | defense response to protozoan (GO:0042832) | 3.50171572 |
| 58 | detection of biotic stimulus (GO:0009595) | 3.48377734 |
| 59 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.48119684 |
| 60 | cellular response to type I interferon (GO:0071357) | 3.47553855 |
| 61 | type I interferon signaling pathway (GO:0060337) | 3.47553855 |
| 62 | response to type I interferon (GO:0034340) | 3.46525298 |
| 63 | B cell mediated immunity (GO:0019724) | 3.41590863 |
| 64 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.39212672 |
| 65 | response to host (GO:0075136) | 3.39212672 |
| 66 | response to host defenses (GO:0052200) | 3.39212672 |
| 67 | negative thymic T cell selection (GO:0045060) | 3.34860934 |
| 68 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.34835660 |
| 69 | neutrophil mediated immunity (GO:0002446) | 3.30298514 |
| 70 | regulation of antigen processing and presentation (GO:0002577) | 3.30064363 |
| 71 | leukocyte degranulation (GO:0043299) | 3.29343938 |
| 72 | cellular response to interleukin-15 (GO:0071350) | 3.28317986 |
| 73 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.27839922 |
| 74 | positive regulation of antigen processing and presentation (GO:0002579) | 3.26595637 |
| 75 | regulation of leukocyte degranulation (GO:0043300) | 3.22832522 |
| 76 | negative T cell selection (GO:0043383) | 3.22531019 |
| 77 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.21969369 |
| 78 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.17696986 |
| 79 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.17696986 |
| 80 | activated T cell proliferation (GO:0050798) | 3.15391378 |
| 81 | positive regulation of interferon-alpha production (GO:0032727) | 3.13520866 |
| 82 | positive T cell selection (GO:0043368) | 3.12470941 |
| 83 | response to protozoan (GO:0001562) | 3.11124029 |
| 84 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.09883006 |
| 85 | negative regulation of phagocytosis (GO:0050765) | 3.08376964 |
| 86 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.06187766 |
| 87 | regulation of interferon-alpha production (GO:0032647) | 3.03679393 |
| 88 | regulation of T cell tolerance induction (GO:0002664) | 3.03205441 |
| 89 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.02587085 |
| 90 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.01494373 |
| 91 | negative regulation of interleukin-6 production (GO:0032715) | 3.00822627 |
| 92 | regulation of tolerance induction (GO:0002643) | 3.00075033 |
| 93 | T cell selection (GO:0045058) | 2.99765174 |
| 94 | response to muramyl dipeptide (GO:0032495) | 2.98934377 |
| 95 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.98701397 |
| 96 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.98490739 |
| 97 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.97987731 |
| 98 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.96941024 |
| 99 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.94275392 |
| 100 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.91866560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.60973362 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.95552934 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.56523145 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.02224596 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.54140186 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.38295248 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.35482931 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.35153901 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.28531026 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.14107536 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.88786381 |
| 12 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.68632034 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.58205481 |
| 14 | SPI1_23127762_ChIP-Seq_K562_Human | 2.56338487 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50623902 |
| 16 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.45186619 |
| 17 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.39251796 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.34416302 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.34085344 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.33718098 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30283801 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.27802679 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.26081763 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.07110201 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 2.06422451 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05850745 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.02685344 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.96861509 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.93298110 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91965784 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 1.91237636 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.87867872 |
| 33 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.81320236 |
| 34 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.79096596 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76248328 |
| 36 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74551517 |
| 37 | GATA3_26560356_Chip-Seq_TH2_Human | 1.66715341 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.65125884 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64298418 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63707619 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.55285182 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48414322 |
| 43 | MAF_26560356_Chip-Seq_TH2_Human | 1.46802338 |
| 44 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46191677 |
| 45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.43992671 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.42671827 |
| 47 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.42183049 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38912548 |
| 49 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38438565 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36184506 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.35509736 |
| 52 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32437559 |
| 53 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32066558 |
| 54 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28752680 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28457198 |
| 56 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.24843339 |
| 57 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.21583444 |
| 58 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20577150 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17511220 |
| 60 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15335184 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14877909 |
| 62 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13759386 |
| 63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12625945 |
| 64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11995936 |
| 65 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.11417141 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11362612 |
| 67 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.11056561 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10946896 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09421323 |
| 70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09159453 |
| 71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.08258748 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06741244 |
| 73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05354717 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02825797 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99643753 |
| 76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96920721 |
| 77 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.95703806 |
| 78 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94694022 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94528512 |
| 80 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94433558 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93469132 |
| 82 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89273108 |
| 83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89077079 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88124943 |
| 85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.87938132 |
| 86 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87752701 |
| 87 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85683490 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85185037 |
| 89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.84948936 |
| 90 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83163620 |
| 91 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.82333737 |
| 92 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80558188 |
| 93 | P300_27268052_Chip-Seq_Bcells_Human | 0.78771996 |
| 94 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74341035 |
| 95 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73974182 |
| 96 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.73576202 |
| 97 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.72645306 |
| 98 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72572582 |
| 99 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.72098212 |
| 100 | GATA3_26560356_Chip-Seq_TH1_Human | 0.71107370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.30337217 |
| 2 | MP0003724_increased_susceptibility_to | 4.29051697 |
| 3 | MP0003436_decreased_susceptibility_to | 3.90568683 |
| 4 | MP0003303_peritoneal_inflammation | 3.79438398 |
| 5 | MP0005671_abnormal_response_to | 3.38516233 |
| 6 | MP0001800_abnormal_humoral_immune | 3.35462623 |
| 7 | MP0005387_immune_system_phenotype | 3.29024758 |
| 8 | MP0001790_abnormal_immune_system | 3.29024758 |
| 9 | MP0002419_abnormal_innate_immunity | 3.08723767 |
| 10 | MP0005000_abnormal_immune_tolerance | 3.05473287 |
| 11 | MP0000685_abnormal_immune_system | 2.98842107 |
| 12 | MP0009785_altered_susceptibility_to | 2.93924802 |
| 13 | MP0005025_abnormal_response_to | 2.90068044 |
| 14 | MP0002723_abnormal_immune_serum | 2.82304573 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.80558565 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.66632335 |
| 17 | MP0001819_abnormal_immune_cell | 2.64071941 |
| 18 | MP0006082_CNS_inflammation | 2.50959712 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.45696560 |
| 20 | MP0001986_abnormal_taste_sensitivity | 2.24533200 |
| 21 | MP0003763_abnormal_thymus_physiology | 2.19015899 |
| 22 | MP0002405_respiratory_system_inflammati | 2.04385594 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.02358731 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.99592200 |
| 25 | MP0002398_abnormal_bone_marrow | 1.97473472 |
| 26 | MP0000716_abnormal_immune_system | 1.97013991 |
| 27 | MP0005310_abnormal_salivary_gland | 1.93161150 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.88122295 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.87076790 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.85100057 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.75569066 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.73202375 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.69246363 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.69190184 |
| 35 | MP0009764_decreased_sensitivity_to | 1.66055238 |
| 36 | MP0002722_abnormal_immune_system | 1.58090998 |
| 37 | MP0009278_abnormal_bone_marrow | 1.54052056 |
| 38 | MP0003866_abnormal_defecation | 1.53114303 |
| 39 | MP0002429_abnormal_blood_cell | 1.52399988 |
| 40 | MP0002132_abnormal_respiratory_system | 1.48352322 |
| 41 | MP0008469_abnormal_protein_level | 1.47981148 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.44513286 |
| 43 | MP0004947_skin_inflammation | 1.42886079 |
| 44 | MP0004381_abnormal_hair_follicle | 1.38653689 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.36347374 |
| 46 | MP0003828_pulmonary_edema | 1.29836541 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.29746047 |
| 48 | MP0008260_abnormal_autophagy | 1.29163963 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.27875301 |
| 50 | MP0005075_abnormal_melanosome_morpholog | 1.26550556 |
| 51 | MP0002277_abnormal_respiratory_mucosa | 1.20904241 |
| 52 | MP0004883_abnormal_blood_vessel | 1.17336214 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.16779281 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.16779281 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.12023143 |
| 56 | MP0003690_abnormal_glial_cell | 1.06927704 |
| 57 | MP0003075_altered_response_to | 1.05761840 |
| 58 | MP0005451_abnormal_body_composition | 1.04382430 |
| 59 | MP0002998_abnormal_bone_remodeling | 0.97306788 |
| 60 | MP0000569_abnormal_digit_pigmentation | 0.97001849 |
| 61 | MP0002166_altered_tumor_susceptibility | 0.96468495 |
| 62 | MP0005166_decreased_susceptibility_to | 0.96305295 |
| 63 | MP0001853_heart_inflammation | 0.93003031 |
| 64 | MP0000015_abnormal_ear_pigmentation | 0.92147582 |
| 65 | MP0000343_altered_response_to | 0.91189281 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 0.90154201 |
| 67 | MP0001663_abnormal_digestive_system | 0.88765102 |
| 68 | MP0004510_myositis | 0.86441923 |
| 69 | MP0001873_stomach_inflammation | 0.86204059 |
| 70 | MP0008004_abnormal_stomach_pH | 0.84156713 |
| 71 | MP0003787_abnormal_imprinting | 0.83739253 |
| 72 | MP0001851_eye_inflammation | 0.83638714 |
| 73 | MP0009763_increased_sensitivity_to | 0.80814128 |
| 74 | MP0000858_altered_metastatic_potential | 0.80218103 |
| 75 | MP0005164_abnormal_response_to | 0.77754526 |
| 76 | MP0003252_abnormal_bile_duct | 0.75857337 |
| 77 | MP0005058_abnormal_lysosome_morphology | 0.73173582 |
| 78 | MP0002928_abnormal_bile_duct | 0.71394778 |
| 79 | MP0009765_abnormal_xenobiotic_induced | 0.70693018 |
| 80 | MP0000604_amyloidosis | 0.68691625 |
| 81 | MP0003045_fibrosis | 0.67164959 |
| 82 | MP0000249_abnormal_blood_vessel | 0.66397019 |
| 83 | MP0003448_altered_tumor_morphology | 0.64437838 |
| 84 | MP0002693_abnormal_pancreas_physiology | 0.63736608 |
| 85 | MP0003195_calcinosis | 0.63725863 |
| 86 | MP0005174_abnormal_tail_pigmentation | 0.62809749 |
| 87 | MP0008874_decreased_physiological_sensi | 0.61920995 |
| 88 | MP0004808_abnormal_hematopoietic_stem | 0.61635004 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 0.60330640 |
| 90 | MP0002006_tumorigenesis | 0.58910157 |
| 91 | MP0005390_skeleton_phenotype | 0.58781696 |
| 92 | MP0002653_abnormal_ependyma_morphology | 0.58377471 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.57783105 |
| 94 | MP0000490_abnormal_crypts_of | 0.57591429 |
| 95 | MP0000371_diluted_coat_color | 0.54609440 |
| 96 | MP0003646_muscle_fatigue | 0.53328703 |
| 97 | MP0002933_joint_inflammation | 0.53294328 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.52708603 |
| 99 | MP0005377_hearing/vestibular/ear_phenot | 0.49039488 |
| 100 | MP0003878_abnormal_ear_physiology | 0.49039488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 6.04672186 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.98862527 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.96714253 |
| 4 | Myositis (HP:0100614) | 5.35709160 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.15420094 |
| 6 | Orchitis (HP:0100796) | 5.02259799 |
| 7 | Optic neuritis (HP:0100653) | 4.96028579 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 4.96028579 |
| 9 | Stomatitis (HP:0010280) | 4.92929696 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.64106393 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.59335339 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.49641659 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 4.46227426 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.42336471 |
| 15 | Meningitis (HP:0001287) | 4.42141449 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 4.22509239 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.22509239 |
| 18 | Recurrent skin infections (HP:0001581) | 4.18959442 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 4.04481974 |
| 20 | Obstructive lung disease (HP:0006536) | 4.04481974 |
| 21 | Encephalitis (HP:0002383) | 3.92037753 |
| 22 | Gastrointestinal infarctions (HP:0005244) | 3.81940929 |
| 23 | Vasculitis (HP:0002633) | 3.81888708 |
| 24 | Spontaneous hematomas (HP:0007420) | 3.58759154 |
| 25 | Keratoconjunctivitis sicca (HP:0001097) | 3.45156641 |
| 26 | Hemoptysis (HP:0002105) | 3.40951951 |
| 27 | Panhypogammaglobulinemia (HP:0003139) | 3.34268857 |
| 28 | Keratoconjunctivitis (HP:0001096) | 3.31271429 |
| 29 | Gingivitis (HP:0000230) | 3.28109925 |
| 30 | Urticaria (HP:0001025) | 3.20510256 |
| 31 | Prolonged bleeding time (HP:0003010) | 3.20425019 |
| 32 | Pulmonary infiltrates (HP:0002113) | 3.17214684 |
| 33 | Chest pain (HP:0100749) | 3.15542869 |
| 34 | T lymphocytopenia (HP:0005403) | 3.11974808 |
| 35 | Abnormality of T cell number (HP:0011839) | 3.10441952 |
| 36 | Agammaglobulinemia (HP:0004432) | 3.10322151 |
| 37 | Inflammation of the large intestine (HP:0002037) | 3.07253882 |
| 38 | Recurrent viral infections (HP:0004429) | 2.99440210 |
| 39 | Increased IgE level (HP:0003212) | 2.98258475 |
| 40 | Episodic fever (HP:0001954) | 2.92017518 |
| 41 | Cellulitis (HP:0100658) | 2.91127765 |
| 42 | Gastrointestinal inflammation (HP:0004386) | 2.89450819 |
| 43 | Abnormality of T cells (HP:0002843) | 2.89061664 |
| 44 | Leukocytosis (HP:0001974) | 2.85519138 |
| 45 | Pustule (HP:0200039) | 2.81107054 |
| 46 | Hypochromic anemia (HP:0001931) | 2.76672340 |
| 47 | Lymphopenia (HP:0001888) | 2.74647212 |
| 48 | Hypochromic microcytic anemia (HP:0004840) | 2.72478822 |
| 49 | Chronic otitis media (HP:0000389) | 2.69029871 |
| 50 | Recurrent bronchitis (HP:0002837) | 2.65858800 |
| 51 | Gingival bleeding (HP:0000225) | 2.64598221 |
| 52 | Osteomyelitis (HP:0002754) | 2.64181564 |
| 53 | Colitis (HP:0002583) | 2.61712736 |
| 54 | Anorexia (HP:0002039) | 2.61464576 |
| 55 | Pulmonary embolism (HP:0002204) | 2.61462448 |
| 56 | Abnormality of the pleura (HP:0002103) | 2.59488546 |
| 57 | Epistaxis (HP:0000421) | 2.57799771 |
| 58 | Arterial thrombosis (HP:0004420) | 2.56548924 |
| 59 | Increased cerebral lipofuscin (HP:0011813) | 2.56535724 |
| 60 | Abnormality of T cell physiology (HP:0011840) | 2.53990771 |
| 61 | Increased IgM level (HP:0003496) | 2.53235334 |
| 62 | Gastrointestinal stroma tumor (HP:0100723) | 2.53182267 |
| 63 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.52248208 |
| 64 | Petechiae (HP:0000967) | 2.48497575 |
| 65 | Recurrent sinusitis (HP:0011108) | 2.44762911 |
| 66 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.37163019 |
| 67 | Sepsis (HP:0100806) | 2.36398382 |
| 68 | Granulocytopenia (HP:0001913) | 2.35810451 |
| 69 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.33009682 |
| 70 | Gangrene (HP:0100758) | 2.25405805 |
| 71 | Recurrent pneumonia (HP:0006532) | 2.21958246 |
| 72 | Amyloidosis (HP:0011034) | 2.16115461 |
| 73 | Eosinophilia (HP:0001880) | 2.13371438 |
| 74 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.10576460 |
| 75 | Viral hepatitis (HP:0006562) | 2.10153612 |
| 76 | Abnormality of the peritoneum (HP:0002585) | 2.10062055 |
| 77 | Alveolar cell carcinoma (HP:0006519) | 2.09537263 |
| 78 | Hematochezia (HP:0002573) | 2.08626416 |
| 79 | Restrictive lung disease (HP:0002091) | 2.07561744 |
| 80 | IgG deficiency (HP:0004315) | 2.06590212 |
| 81 | Abnormality of the prostate (HP:0008775) | 2.06365879 |
| 82 | Autoimmune thrombocytopenia (HP:0001973) | 2.06179919 |
| 83 | IgM deficiency (HP:0002850) | 2.04905936 |
| 84 | Microcytic anemia (HP:0001935) | 2.04772186 |
| 85 | Abnormality of the endocardium (HP:0004306) | 2.03780444 |
| 86 | Vertigo (HP:0002321) | 2.02486256 |
| 87 | Purpura (HP:0000979) | 2.02280221 |
| 88 | Stomach cancer (HP:0012126) | 2.01612327 |
| 89 | Skin rash (HP:0000988) | 2.00451138 |
| 90 | Loss of speech (HP:0002371) | 1.99996470 |
| 91 | Abnormality of eosinophils (HP:0001879) | 1.97786850 |
| 92 | Polyneuropathy (HP:0001271) | 1.96101473 |
| 93 | Systemic lupus erythematosus (HP:0002725) | 1.95703878 |
| 94 | Keratitis (HP:0000491) | 1.95352020 |
| 95 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.95087365 |
| 96 | Recurrent lower respiratory tract infections (HP:0002783) | 1.93599228 |
| 97 | Vacuolated lymphocytes (HP:0001922) | 1.93101255 |
| 98 | Hypergammaglobulinemia (HP:0010702) | 1.92769951 |
| 99 | Cheilitis (HP:0100825) | 1.92235087 |
| 100 | Verrucae (HP:0200043) | 1.89906261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.64562390 |
| 2 | BLK | 4.58497835 |
| 3 | MAP4K1 | 4.55675373 |
| 4 | IRAK4 | 3.20444232 |
| 5 | TYK2 | 2.97562035 |
| 6 | ERN1 | 2.89525263 |
| 7 | FES | 2.59354050 |
| 8 | CSK | 2.52988653 |
| 9 | TNK2 | 2.34566372 |
| 10 | MAP2K3 | 2.22379457 |
| 11 | BTK | 2.10882316 |
| 12 | SYK | 2.08045722 |
| 13 | TXK | 1.97126135 |
| 14 | GRK6 | 1.93101602 |
| 15 | MAP3K14 | 1.89450499 |
| 16 | CSF1R | 1.88332359 |
| 17 | FGR | 1.80625821 |
| 18 | ZAP70 | 1.76834097 |
| 19 | IKBKE | 1.76317215 |
| 20 | TAOK3 | 1.76101288 |
| 21 | LYN | 1.66665918 |
| 22 | HCK | 1.60585877 |
| 23 | TEC | 1.54472910 |
| 24 | MAP3K13 | 1.48623659 |
| 25 | KIT | 1.43233714 |
| 26 | TAOK1 | 1.42679732 |
| 27 | JAK1 | 1.35840782 |
| 28 | * JAK3 | 1.33512220 |
| 29 | JAK2 | 1.32300664 |
| 30 | EPHB1 | 1.28344410 |
| 31 | MAP3K11 | 1.27915379 |
| 32 | ACVR1B | 1.25157057 |
| 33 | FRK | 1.22936254 |
| 34 | MARK3 | 1.22605236 |
| 35 | IRAK1 | 1.21548511 |
| 36 | MATK | 1.20128586 |
| 37 | TBK1 | 1.19212731 |
| 38 | MAP3K3 | 1.18893433 |
| 39 | * LCK | 1.17375562 |
| 40 | IKBKB | 1.11756558 |
| 41 | SIK3 | 1.04185267 |
| 42 | PRPF4B | 1.02558978 |
| 43 | PDK1 | 1.00766957 |
| 44 | PIK3CG | 0.99241637 |
| 45 | BMPR2 | 0.91386031 |
| 46 | * ITK | 0.89630421 |
| 47 | MAP3K1 | 0.89403855 |
| 48 | IRAK2 | 0.85704531 |
| 49 | YES1 | 0.82796142 |
| 50 | SIK2 | 0.80100592 |
| 51 | OXSR1 | 0.78237445 |
| 52 | KSR2 | 0.76548038 |
| 53 | CDK19 | 0.75830692 |
| 54 | PRKCQ | 0.71931515 |
| 55 | ADRBK2 | 0.69716788 |
| 56 | MAPK12 | 0.67791075 |
| 57 | PTK2B | 0.67704248 |
| 58 | GRK7 | 0.67627040 |
| 59 | DAPK2 | 0.67536861 |
| 60 | MARK2 | 0.67375541 |
| 61 | STK11 | 0.66959015 |
| 62 | PDPK1 | 0.66057999 |
| 63 | TGFBR2 | 0.63417255 |
| 64 | STK10 | 0.61928888 |
| 65 | PTK6 | 0.57775285 |
| 66 | MAPK7 | 0.57446457 |
| 67 | PRKD2 | 0.56247660 |
| 68 | CDC42BPA | 0.56100292 |
| 69 | * FYN | 0.54019845 |
| 70 | MAP3K5 | 0.52584806 |
| 71 | CAMKK2 | 0.51636492 |
| 72 | MAP2K4 | 0.50401952 |
| 73 | NLK | 0.49866185 |
| 74 | CAMK1D | 0.47042524 |
| 75 | HIPK2 | 0.44962546 |
| 76 | MAP3K7 | 0.44890317 |
| 77 | ABL1 | 0.43963846 |
| 78 | PIM1 | 0.43775320 |
| 79 | MAP2K6 | 0.39659325 |
| 80 | EPHA3 | 0.39547272 |
| 81 | SGK2 | 0.39272475 |
| 82 | SGK3 | 0.38713366 |
| 83 | PRKCZ | 0.37944141 |
| 84 | RPS6KA6 | 0.37273974 |
| 85 | FGFR3 | 0.35954964 |
| 86 | LRRK2 | 0.35490571 |
| 87 | TAOK2 | 0.35367092 |
| 88 | MAP3K2 | 0.34215292 |
| 89 | RPS6KL1 | 0.33038384 |
| 90 | RPS6KC1 | 0.33038384 |
| 91 | MAP2K2 | 0.30708840 |
| 92 | MAPKAPK2 | 0.30348993 |
| 93 | CAMKK1 | 0.28988581 |
| 94 | ADRBK1 | 0.28028515 |
| 95 | CAMK4 | 0.27800175 |
| 96 | MAP3K6 | 0.25343628 |
| 97 | PRKCD | 0.23086062 |
| 98 | NEK9 | 0.22673377 |
| 99 | CHUK | 0.22506830 |
| 100 | INSR | 0.22458297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.33777785 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.11707262 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.99198026 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.96993316 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.85692414 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.76070522 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.63147056 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.57123673 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.32575204 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.29869008 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.28419429 |
| 12 | Asthma_Homo sapiens_hsa05310 | 2.25406737 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.25022357 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.04066221 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.03926781 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.98699852 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.95093175 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.93483952 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.86217106 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.78834507 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.70527606 |
| 22 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.62363922 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.61835945 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.59723565 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.55971848 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53568751 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.49532680 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.48766658 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.45631703 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.40993141 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.38344634 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.36843927 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.35711520 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.30705061 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.25594924 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.25054175 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23106941 |
| 38 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.18174306 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10996329 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.10775878 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.10007790 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06969276 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97965910 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96132054 |
| 45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.94503890 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 0.92143959 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 0.90316692 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 0.86774977 |
| 49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83538923 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79114183 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78575877 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78332937 |
| 53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72921128 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.71452443 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71398847 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66176479 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65519356 |
| 58 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63595429 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62687038 |
| 60 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61891926 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 0.61876243 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61406692 |
| 63 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60560108 |
| 64 | Shigellosis_Homo sapiens_hsa05131 | 0.58702139 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54545237 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54386930 |
| 67 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51263146 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50276075 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48463672 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47920578 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47150426 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.44328924 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43170089 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42521010 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41999454 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40641981 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40219643 |
| 78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39266650 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38342254 |
| 80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.37011262 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36634476 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36588309 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36434661 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35220971 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35187714 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.34665942 |
| 87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34530107 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34195390 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34110875 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34052680 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33725647 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33223555 |
| 93 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.32200720 |
| 94 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.31064536 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30957707 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.30370884 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.30045774 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29110549 |
| 99 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.24459911 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.24347286 |

